Informing a European guidance framework on electronic informed consent in clinical research: a qualitative study by Evelien De Sutter, Pascal Borry, Isabelle Huys, Liese Barbier

Get full text

Off-Patent Biologicals and Biosimilars Tendering in Europe—A Proposal towards More Sustainable Practices by Liese Barbier, Steven Simoens, Caroline Soontjens, Barbara Claus, Arnold G. Vulto, Isabelle Huys

Get full text

Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians by Liese Barbier, Yannick Vandenplas, Steven Simoens, Paul Declerck, Arnold G. Vulto, Isabelle Huys

Get full text

Biosimilar Use and Switching in Belgium: Avenues for Integrated Policymaking by Liese Barbier, Steven Simoens, Paul Declerck, Arnold G. Vulto, Arnold G. Vulto, Isabelle Huys

Get full text

Personalized and longitudinal electronic informed consent in clinical trials: How to move the needle? by Evelien De Sutter, Liese Barbier, Pascal Borry, David Geerts, John P.A. Ioannidis, Isabelle Huys

Get full text

Testing and Practical Implementation of a User-Friendly Personalized and Long-Term Electronic Informed Consent Prototype in Clinical Research: Mixed Methods Study by Evelien De Sutter, David Geerts, Koen Yskout, Stef Verreydt, Pascal Borry, Liese Barbier, Isabelle Huys

Get full text

Regulatory Information and Guidance on Biosimilars and Their Use Across Europe: A Call for Strengthened One Voice Messaging by Liese Barbier, Allary Mbuaki, Steven Simoens, Paul Declerck, Arnold G. Vulto, Arnold G. Vulto, Isabelle Huys

Get full text

Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey by Isabelle Arnet, Melina Verbeek, Birna Almarsdóttir Anna, Liese Barbier, Rhonda Clifford, Christiane Eickhoff, Kurt Hersberger, Isabelle Huys, Kenny Lee, Kritsanee Saramunee, Martin Schulz, David Zgarrick, Kati Sarnola

Get full text

How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action by Rosanne Janssens, Liese Barbier, Mireille Muller, Irina Cleemput, Isabelle Stoeckert, Chiara Whichello, Bennett Levitan, Tarek A. Hammad, Charis Girvalaki, Juan-Jose Ventura, Karin Schölin Bywall, Karin Schölin Bywall, Cathy Anne Pinto, Elise Schoefs, Eva G. Katz, Ulrik Kihlbom, Isabelle Huys

Get full text

How to balance valuable innovation with affordable access to medicines in Belgium? by Steven Simoens, Khadidja Abdallah, Liese Barbier, Teresa Barcina Lacosta, Alessandra Blonda, Elif Car, Zilke Claessens, Thomas Desmet, Evelien De Sutter, Laurenz Govaerts, Rosanne Janssens, Teodora Lalova, Teodora Lalova, Evelien Moorkens, Robbe Saesen, Robbe Saesen, Elise Schoefs, Yannick Vandenplas, Eline Van Overbeeke, Ciska Verbaanderd, Ciska Verbaanderd, Isabelle Huys

Get full text